Alpha Cognition, Inc. (NASDAQ:ACOG – Free Report) – Investment analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Alpha Cognition in a report issued on Monday, March 31st. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.38) per share for the quarter, up from their previous estimate of ($0.72). HC Wainwright currently has a “Buy” rating and a $20.00 target price on the stock.
Separately, Raymond James upgraded Alpha Cognition to a “moderate buy” rating in a report on Tuesday, March 25th.
Alpha Cognition Price Performance
Shares of ACOG stock opened at $5.08 on Thursday. Alpha Cognition has a 12-month low of $4.66 and a 12-month high of $7.00. The stock’s fifty day moving average is $5.79. The company has a market capitalization of $81.38 million, a P/E ratio of -1.98 and a beta of 2.50.
Alpha Cognition (NASDAQ:ACOG – Get Free Report) last announced its quarterly earnings data on Monday, March 31st. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.48) by ($0.03).
Institutional Trading of Alpha Cognition
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Rosalind Advisors Inc. bought a new position in shares of Alpha Cognition in the 4th quarter valued at about $1,489,000. National Bank of Canada FI acquired a new position in shares of Alpha Cognition in the fourth quarter valued at approximately $69,000. Aristides Capital LLC bought a new position in shares of Alpha Cognition during the fourth quarter worth approximately $1,178,000. ADAR1 Capital Management LLC acquired a new stake in Alpha Cognition during the 4th quarter worth approximately $1,204,000. Finally, Altium Capital Management LLC acquired a new stake in shares of Alpha Cognition during the fourth quarter worth $1,620,000.
About Alpha Cognition
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Featured Articles
- Five stocks we like better than Alpha Cognition
- Growth Stocks: What They Are, Examples and How to Invest
- Tesla Stock: What To Expect With Their Delivery Numbers Report
- Stock Analyst Ratings and Canadian Analyst Ratings
- First Watch Restaurant Group: A First-Rate Small-Cap Growth Stock
- Stock Dividend Cuts Happen Are You Ready?
- Rocket Lab: $5.6 Billion Defense Contract Fuels RKLB’s Future
Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
